- Image via Wikipedia
Βαβυλὼν ἡ μεγάλη πόλις….
καὶ φῶς λύχνου οὐ μὴ φάνῃ ἐν σοὶ ἔτι, καὶ φωνὴ νυμφίου καὶ νύμφης οὐ μὴ ἀκουσθῇ ἐν σοὶ ἔτι· ὅτι οἱ ἔμποροί σου ἦσαν οἱ μεγιστᾶνες τῆς γῆς, ὅτι ἐν τῇ φαρμακείᾳ σου ἐπλανήθησαν πάντα τὰ ἔθνη,
Say…that life saving medicine… your life, but others? Not so much.
You wouldn’t think the cities had much in common. Iaşi, with a population of 320,000, lies in the Moldavian region of Romania. Mégrine is a town of 24,000 in northern Tunisia, on the Mediterranean Sea. Tartu, Estonia, with a population of 100,000, is the oldest city in the Baltic States; it is sometimes called “the Athens on the Emajõgi.” Shenyang, in northeastern China, is a major industrial center and transportation hub with a population of 7.2 million.
These places are not on anyone’s Top 10 list of travel destinations. But the advance scouts of the pharmaceutical industry have visited all of them, and scores of similar cities and towns, large and small, in far-flung corners of the planet. They have gone there to find people willing to undergo clinical trials for new drugs, and thereby help persuade the U.S. Food and Drug Administration to declare the drugs safe and effective for Americans. It’s the next big step in globalization, and there’s good reason to wish that it weren’t.
Deadly Medicine | Politics | Vanity Fair.
You have to read this article.
Related articles
- Martha Rosenberg | Is Pfizer the BP of Drug Companies? (yubanet.com)
Joel Landon Watts is a Masters of Theological Studies student with a focus in Mimetic Criticism of the Gospel of Mark. His interests include exploring the role of mimesis in human civilization, specifically in the study of religion and media, as well as science fiction and the way in which it has allowed mythology to be explored in light of scientific ideals of the past century. Currently, he is a TA for Old Testament at United Theological Seminary under Dr. Vivian Johnson, Associate Professor of Old Testament. His first book, Rhetorical Strategies of the Evangelist: Mimetic Criticism of the Gospel of Mark, is expected to be published by Wipf and Stock early next year. He is currently co-editing a book on moving from Fear to Faith (Energion, 2013).
